Maziar Mike Doustdar appointed President and CEO of Novo Nordisk
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Revenue increased 11.4 per cent to Rs. 8,545 crore
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
Subscribe To Our Newsletter & Stay Updated